Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration.

Abstract : UNLABELLED: ABSTRACT: BACKGROUND: Leber's hereditary optic neuropathy (LHON) is caused by mutations in the complex I subunits of the respiratory chain. Although patients have been treated with idebenone since 1992, the efficacy of the drug is still a matter of debate. METHODS: We evaluated the effect of idebenone in fibroblasts from LHON patients using enzymatic and polarographic measurements. RESULTS: Complex I activity was 42% greater in treated fibroblasts compared to controls (p = 0.002). Despite this complex I activity improvement, the effects on mitochondrial respiration were contradictory, leading to impairment in some cases and stimulation in others. CONCLUSION: These results indicate that idebenone is able to compensate the complex I deficiency in LHON patient cells with variable effects on respiration, indicating that the patients might not be equally likely to benefit from the treatment.
Type de document :
Article dans une revue
BMC Research Notes, BioMed Central, 2011, 4 (1), pp.557. 〈10.1186/1756-0500-4-557〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00673659
Contributeur : Ed. Bmc <>
Soumis le : jeudi 23 février 2012 - 21:06:10
Dernière modification le : lundi 5 février 2018 - 15:00:09
Document(s) archivé(s) le : vendredi 23 novembre 2012 - 14:30:39

Identifiants

Collections

Citation

Claire Angebault, Naïg Gueguen, Valérie Desquiret-Dumas, Arnaud Chevrollier, Virginie Guillet, et al.. Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration.. BMC Research Notes, BioMed Central, 2011, 4 (1), pp.557. 〈10.1186/1756-0500-4-557〉. 〈inserm-00673659〉

Partager

Métriques

Consultations de la notice

292

Téléchargements de fichiers

324